|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.135 USD | +4.58% |
|
+0.29% | -67.42% |
| 12-03 | Orion Lifts FY25 Outlook on Expectation of Milestone Payment for Prostate Cancer Drug | MT |
| 11-19 | Orion S.A. Gains Commercial Traction with Conductive Additives Vital for Grid Modernization | CI |
Company Valuation: Orion S.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,037 | 1,113 | 1,083 | 1,610 | 911.4 | 275.7 | - | - |
| Change | - | 7.38% | -2.7% | 48.6% | -43.38% | -69.75% | - | - |
| Enterprise Value (EV) 1 | 1,710 | 1,830 | 1,938 | 2,386 | 1,773 | 1,217 | 1,199 | 1,191 |
| Change | - | 7.02% | 5.88% | 23.13% | -25.7% | -31.36% | -1.47% | -0.68% |
| P/E ratio | 57.1x | 8.31x | 10.3x | 16x | 20.8x | -4.55x | 9.44x | 5.58x |
| PBR | 5.73x | 3.48x | 2.35x | 3.36x | 1.9x | 0.71x | 0.68x | 0.61x |
| PEG | - | 0x | -0.5x | - | -0.4x | 0x | -0x | 0.1x |
| Capitalization / Revenue | 0.91x | 0.72x | 0.53x | 0.85x | 0.49x | 0.16x | 0.16x | 0.15x |
| EV / Revenue | 1.51x | 1.18x | 0.95x | 1.26x | 0.94x | 0.7x | 0.7x | 0.67x |
| EV / EBITDA | 8.55x | 6.83x | 6.21x | 7.18x | 5.87x | 5.34x | 5.15x | 4.6x |
| EV / EBIT | 16.5x | 11.2x | 9.38x | 10.9x | 10x | 11.6x | 10.4x | 8.71x |
| EV / FCF | -87x | -26.3x | -12.8x | 13.8x | - | 33.8x | 40x | 62.7x |
| FCF Yield | -1.15% | -3.8% | -7.84% | 7.25% | - | 2.96% | 2.5% | 1.6% |
| Dividend per Share 2 | 0.2 | 0.0207 | 0.08 | 0.08 | 0.08 | 0.0841 | 0.0926 | 0.1009 |
| Rate of return | 1.17% | 0.11% | 0.45% | 0.29% | 0.51% | 1.71% | 1.89% | 2.05% |
| EPS 2 | 0.3 | 2.21 | 1.73 | 1.73 | 0.76 | -1.08 | 0.52 | 0.88 |
| Distribution rate | 66.7% | 0.94% | 4.62% | 4.62% | 10.5% | -7.79% | 17.8% | 11.5% |
| Net sales 1 | 1,136 | 1,547 | 2,031 | 1,894 | 1,878 | 1,747 | 1,714 | 1,789 |
| EBITDA 1 | 200 | 268 | 312.3 | 332.3 | 302.2 | 228 | 232.8 | 258.9 |
| EBIT 1 | 103.5 | 163.9 | 206.6 | 219.3 | 176.9 | 105 | 115.7 | 136.7 |
| Net income 1 | 18.16 | 134.7 | 106.2 | 103.5 | 44.2 | -60.8 | 29.4 | 49.7 |
| Net Debt 1 | 673.6 | 717.2 | 855 | 776.8 | 861.6 | 941.4 | 923.4 | 915.3 |
| Reference price 2 | 17.140 | 18.360 | 17.810 | 27.730 | 15.790 | 4.910 | 4.910 | 4.910 |
| Nbr of stocks (in thousands) | 60,487 | 60,633 | 60,816 | 58,044 | 57,720 | 56,150 | - | - |
| Announcement Date | 2/18/21 | 2/17/22 | 2/16/23 | 2/14/24 | 2/19/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.55x | 0.7x | 5.34x | 1.71% | 276M | ||
| 34.72x | 4.82x | 20.08x | 1.03% | 71.74B | ||
| 27.97x | 4.57x | 18.74x | 2.18% | 37.98B | ||
| 22.49x | 2.61x | 13.91x | 2.29% | 31.3B | ||
| 14.95x | 1.43x | 8.97x | 2.12% | 25.4B | ||
| 27.72x | 4.55x | 13.82x | 2.85% | 17.97B | ||
| 19.95x | 2.2x | 8.8x | 1.56% | 16.5B | ||
| 26.71x | 6.02x | 19.63x | 3.43% | 15.49B | ||
| -51.23x | 3.46x | 16.26x | 1.26% | 15.22B | ||
| 442.06x | 7.03x | 74.33x | 0.12% | 13.56B | ||
| Average | 56.08x | 3.74x | 19.99x | 1.85% | 24.54B | |
| Weighted average by Cap. | 45.19x | 4.06x | 19.44x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- OEC Stock
- Valuation Orion S.A.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















